Answer
Xultophy (insulin degludec + liraglutide) is contraindicated in people with hypersensitivity to either or both active substances or any excipient listed in section 6.1 of its prescribing information.
Sources for this answer
- Xultophy 100 units/mL + 3.6 mg/mL solution for injectionNovo Nordisk Limited · emc · SmPC §4.3 Contraindications · Version 6Document updated
Sources checked